
医学资讯Ilofotase alfa,急性肾损伤,心脏手术,肾脏保护
Ilofotase Alfa 预防心脏手术后急性肾损伤:来自2期随机试验的启示
By MedXY|2026年9月25日
一项2期随机试验显示,ilofotase alfa 未能显著降低接受体外循环心脏手术的高危患者的肾损伤或改善临床结局,但其安全性良好、耐受性较好。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.